We continue to improve our approach to impact reporting.
Carrying out R&D using high temperatures and flammable hydrogen can be almost impossible for an SME due to the expensive laboratory infrastructure required. Through the facilities at STFC’s Innovations Technology Access Centre (I-TAC), Designed Materials were able to set up their R&D space and start operating quickly and safely.
A consortium of private companies and research organisations have been using the Science and Technology Facilities Council (STFC)’s ISIS neutron and muon facility to optimise the design of train wheels.
STFC’s ISIS facility has been used to develop a novel material which is designed to improve the treatment of cleft palates, speeding up healing times and reducing operating costs.
STFC funded Diamond Light Source is working with UK industry to better understand Parkinson’s disease, which affects seven million people worldwide.
STFC is providing leading-edge laboratory space for high-tech SMEs to improve their efficiency and competitiveness.
The Science and Technology Facilities Council (STFC)’s Harwell Imaging Partnership (HIP) has provided Luxfer Gas Cylinders with access to testing facilities at the Diamond Light Source in order to optimise the damage resistance of their product designs.
Using the expertise in foot-and-mouth disease at The Pirbright Institute and facilities for determining protein structures at Diamond Light Source and its predecessor the Synchrotron Radiation Source (SRS), researchers have developed a new vaccine against foot-and-mouth disease (FMD).
UK industry working closely with STFC’s Daresbury Laboratory delivers new x-ray scanning technology that enhances airport security, reduces costs and improves passenger confidence.
STFC is providing the design infrastructure for the £23bn UK microelectronics sector, underpinning several other strategically important industries to the UK economy.
Waiting for a replacement organ that never comes is the heart breaking truth for 14% of patients requiring a liver transplant. The demand for replacement livers has always far outweighed the supply, with over 10,000 people waiting for a liver transplant in the EU alone. This means many patients can die, or otherwise become too sick to undergo surgery, during the wait. It is equally troubling that 6% of the EU population suffer from chronic long-term liver diseases. Available technologies for rep